INTRODUCTION
S tudies on the relationship between infl ammation and tumor can be traced back to the 19th century. In 1863, Virchow found infl ammation cells, which presented in tumor biopsy specimens, and proposed the hypothesis that tumors might originate from the site of chronic infl ammation. It has been cleared now that infl ammation is involved in tumor incidence. Infl ammation may promote tumor cell proliferation, angiogenesis and tumor metastasis, infl uence anti-tumor immune responses and even aff ect the response of tumor cells to drug treatment. In 2009, Mantovani et al classifi ed infl ammation as the seventh hallmarks of cancer [1] [2] . Studies on the relationship between infl ammation and tumor have brought far-reaching impacts on diagnosis and treatment of cancer.
INFLAMMATION AND TUMOR
Tumor, a complex aberrant cell aggregate, is composed of tumor parenchyma and stroma. Stroma includes extracellular matrix, endothelial cells which constitute blood vessels and lymphatic vessels, and immune cells. Th e factors involved in tumor infl ammation may derive from tumor cells (intrinsic pathway), or mediated by immune cells (extrinsic pathway). Intrinsic pathway of tumor infl ammation is related to genetic events in tumor cells. Gene mutations in Ras, MYC and microRNA-155, or abnormal activation of VHL/HIF and NF-κB pathway, may promote cell to express cytokines (such as IL-1 and TNF-α), chemokines (such as CXCL5 and CXCL12) and growth factors (such as colony-stimulating factors), which directly participate in or recruit immune cells to participate in tumor infl ammation [2] [3] [4] .
Immune cells involved in tumor infl ammation include tumor-associated macrophages (TAM)-a kind of M2 macrophage, neutrophils, lymphocytes, dendritic cells and mast cells. Th ese immune cells, which are activated by chronic infections (such as HBV, HPV, EBV, H. pylori, etc.) or damaged cells, may produce cytokines, chemokines, adhesion molecules and free radicals to intervene the interaction between tumor cell and extracellular matrix, and participate in tumor initiation, progression and metastasis. In addition, NF-κB, HIF-1α and STAT3 are common transcription factors both in intrinsic and extrinsic tumor infl ammation [2] .
It has been confi rmed that common malignancies such as liver cancer, gastric cancer, cervical cancer, pancreatic cancer, colon cancer and nasopharyngeal cancer are closely related to chronic infl ammation. In tumor initiation phase, infl ammation produces reactive oxygen species (ROS) and reactive nitrogen species (RNS) which may lead to genetic instability, induce DNA damage and mutations, aff ect DNA damage repair through post-translational modifi cations in tumor suppressor genes such as p53 and RB, and promote malignant transformation. Chronic infl ammation can also infl uence the expressions of p16, RUNX3, p53 and other genes by epigenetic mechanisms and involve in malignant transformation [2, [5] [6] . In the development of tumor, infl ammation plays a promoting role, for example, immune cells can secrete cytokines such as IL-1, IL-6 and EGF to promote tumor cell survival, VEGF and IL-8 to promote angiogenesis, TGF-β and MMPs to promote cancer metastasis, IL-10, and TGF-β and CCL17 to suppress anti-tumor immunity. In addition, infl ammation can aff ect the response of hormone treatment and chemotherapy, and targeting infl ammatory pathways have some potential eff ects to improve chemotherapy of cancer [2, [6] [7] [8] .
macrophages (classically activated macrophages) and M2 macrophages (alternatively activated macrophages) [9] [10] [11] . M1 macrophages can be activated by bacterial products, lipopolysaccharides (LPS), interferon-γ and GM-CSF. M1 phagocytes are characterized by an IL-12 high , IL-23 high and IL-10 low phenotype, and executes classic macrophage functions such as antigen-present, and consequent activation of type I immune response. In addition, M1 macrophages expressed iNOS and M2 macrophages expressed Arg1 could competitively combine with L-arginine to produce NO and ROS, which can promote infl ammatory response and clear invading microbes [12] [13] . M1 macrophages present anti-tumor activity in lung cancer and positively correlated with prognosis, activated M1 macrophages also can be used for treatment of liver cancer and other cancers [14] [15] [16] .
M2 macrophages have been divided into at least three subtypes (1): type M2a, induced by IL-4 and IL-13; (2) type M2b, induced by immune complexes in combination with IL-1β or LPS; (3) type M2c, activated by IL-10, TGF-β, or glucocorticoid, and participated to immunoregulation [17] . M2 macrophages are the major cell macrophages in tumor tissue, namely tumor-associated macrophages (TAMs). TAMs express arginase I (Arg-1), which decompose L-arginine to produce L-ornithine, a precursor of proline, and promote collagen synthesis and damaged tissue repair [12] [13] 18] . In addition to the induction of cytokines, Wang et al recently found that Notch signaling is signifi cant in the determination of M1 versus M2 macrophages polarization, blocking Notch signaling could promote macrophage diff erentiation into pro-tumor M2 macrophages, while activating Notch signaling promote macrophage diff erentiation into anti-tumor M1 macrophages [19] . It has been proved in many tumors such as breast cancer and pancreatic cancer, M2 macrophages are closely related with tumor metastasis, showing a negative correlation with prognosis [20] [21] .
TUMOR-ASSOCIATED MACROPHAGES AND CANCER
TAMs are the main cell population involved in chronic tumor infl ammation. TAMs are diff erentiated from monocytes under the induction of cytokines like M-CSF, IL-4, IL -13 and IL-10. In addition, tumor cells secreted cytokines/chemokines such as IL-10, CSF-1, CXCL1 and CCL2, may activate NF-κB and STAT3 signaling pathways and promote monocytes to diff erentiate into TAM which highly express IL-10 and Arg-1 and lowly express IL-12, showing M2 macrophage phenotype and function. Tumor hypoxia environment is also involved in the activation of TAM. Tumor hypoxia environment activates HIF-1a signaling pathway, up-regulates CXCL8 and CXCR4 to activate TAM, and promotes NOS2 and ARG gene expression, thus aff ecting the metabolism of Larginine [17, [22] [23] [24] . TAMs show a poor antigen presenting ability, promote tumor angiogenesis and metastasis, and inhibit anti-tumor immune response [18, [22] [23] [24] . TAMs are enriched at the invasive edges of tumors. Tumor cells secretes CSF-1 to stimulate TAMs to express epidermal growth factors, forming EGF/CSF-1 paracrine loop, thereby promoting tumor cells migration; meanwhile, TAMs expressed SPARC/osteonectin, matrix metalloproteinases (MMPs) and chemokines may infl uence matrix remodeling in tumors, and promotes tumor metastasis. TAM also secretes a variety of proangiogenic factors, such as VEGF, TGF-β, PDGF and FGF, to promote tumor angiogenesis. In addition, TAMs produce immunosuppressive cytokines such as IL-10 and TGF-β, and secrete CCL22 to recruit regulatory T cells (Tregs) to inhibit tumor immunity.
CANCER INFLAMMATION AND TRADITIONAL CHINESE MEDICINE
Cancer is a complex disease. Studies conducted from diff erent perspectives may improve the effi ciency of cancer therapy. In view of eff ects of infl ammation in tumor initiation and development, infl ammatory cells are genetic stable and less prone mutations and drug resistance, infl ammation has become a potential target for cancer prevention and treatment [25] [26] .
Infl ammation targets for tumor treatment include COX-2, NF-κB, cytokines and their receptors, chemokines and their receptors as well as M2 macrophages. Present studies mainly focus on non-steroidal and steroidal anti-infl ammatory drugs, COX-2 inhibitors, plant extracts and biological therapeutics. It has been confi rmed that anti-infl ammatory drugs such as sulindac have not only a certain degree of anti-cancer effects, but also can prevent the incidence of colorectal cancer, lung cancer and other tumors in high-risk populations to some degree and may cooperate with current anti-cancer drugs [26] [27] [28] [29] [30] [31] . It has been reported anti-infl ammatory plant natural products, such as resveratrol, genistein, quecetin, shikonin and epigallocatechin gallate, have been found to have anti-cancer potential [32] [33] .
Chinese herbs are widely used for cancer treatment. Some anti-cancer Chinese herbal components, such as curcumin, resveratrol, quercetin and silibinin, may inhibit tumor infl ammation related gene expression [34] [35] [36] [37] [38] . Curcumin and resveratrol showed potential eff ect for cancer prevention and treatment, to some degree, and a better prospect for clinical application when combing with traditional treatments like chemotherapy [39] [40] [41] [42] . PC-SPES, an eight herbal mixture, may down-regulate COX-2 via inhibition of NF-κB and C/EBPβ in non-small cell lung cancer cells [43] . Tanshinone I, a major compound of Danshen, reduces interleukin-8 by attenuating the DNA-binding activity of activator protein-1 and NF-κB in human lung adenocarcinoma CL1-5 cells [44] . Anti-cancer eff ects of Gypenosides, Berberine, Triptolide and Tribulus terrestris Linn have been found associated with down-regulation of NF-κB pathway [45] [46] [47] [48] . Inhibitory eff ects of Pachymic acid and Celastrol on breast cancer cell invasion were found related to down-regulation of NF-κB-mediated matrix metalloproteinase-9 expression [49] [50] . In addition, Triptolide may decrease colitis induced colon cancer by interrupting the IL6R-JAK/STAT pathway [51] . Ginsenoside Rg3 may inhibit phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion [52] . Tetra-Methylpyrazine could enhance IFN-γ, IL-2 and T-bet, but reduce those of type 2 cytokines in lung cancer patients [53] Table I. However, there is a shortage of study on Chinese herb or herbal ingredient against extrinsic cancer infl ammation, especially in M2 macrophages. Traditional Chinese Medicine is the unique biomedical resource in China. Many Chinese herbs used to treat infl ammatory diseases are also applied for tumor treatment, such as Barbed Skullcap, Hedyotis Diff usa Willd, Solanum Nigrum, rhizoma pardis and Polygonum Cuspidate. In facts, the most frequently used anti-cancer herbs are heat-clearing and detoxifying (Qing-Re-Jie-Du) herbs which are originally used for infl ammatory diseases treatment [56] [57] . It can be speculated that these Chinese herbs may have eff ects on inhibiting cancer-related infl ammation. Related studies may provide new clue for pointedly apply specifi c Chinese herb or components against cancer infl ammation to enhance the overall effi cacy of cancer treatment. Due to space considerations, some reviews are cited rather than original articles, and the authors apologize to the scientists whose works could not be cited.
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